Skip to main content

Institutional intelligence for DCM Shriram Fine Chemicals Limited

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters50.11%
  • FII1.03%
  • DII (ex-MF)11.36%
  • Retail & others37.50%
  • 1% Club 11.23%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

50.11%8 named
HolderStakeSharesValue (₹ Cr)
13.83%1,20,28,267₹29.6 Cr
10.28%89,41,864₹22.0 Cr
10.28%89,42,540₹22.0 Cr
6.77%58,89,611₹14.5 Cr
3.42%29,76,389₹7.3 Cr
2.02%17,57,160₹4.3 Cr
1.76%15,26,766₹3.8 Cr
1.76%15,26,765₹3.8 Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

37.50%

SEBI requires naming only shareholders with ≥1% stake. The remaining 37.50% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

11.23%4 named
HolderStakeSharesValue (₹ Cr)
3.74%32,50,001₹8.0 Cr
3.39%29,46,484₹7.3 Cr
Tracked as Abakkus2.86%24,90,000₹6.1 Cr
1.24%10,78,060₹2.6 Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

11.36%1 named
HolderStakeSharesValue (₹ Cr)
Tracked as LIC4.64%40,36,025₹9.9 Cr

FII / FPI

Foreign portfolio investors

1.03%No names

No named holders ≥1% in this bucket.

Mutual Funds

Domestic mutual funds & UTI

No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.